”NYR-BI03 demonstrated superior efficacy in this study compared to Captopril, anFDA-approved therapy.”
Far superior than catopril huge news that’s what we like to hear. Plus NYR OWN this drug class with more news flow in next fortnight and human trials starts shortly as well
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 35.0¢ | 31.0¢ | $188.4K | 569.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7500 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 30034 | 2 |
View Market Depth
| Last trade - 15.33pm 22/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |